Vivo Infusion acquires Civic Infusion, hitting 36 ASCs

Vivo Infusion has acquired Civic Infusion, a company founded in 2018 to provide solutions for infusion patients in Connecticut and New York.

Advertisement

The acquisition grows Vivo’s presence to 36 ASCs across nine states — Colorado, Connecticut, Florida, Ohio, Oklahoma, Pennsylvania, New York, New Jersey and Texas — according to a Jan. 31 release.

Through the acquisition, co-founders of Civic Barry Stein, MD, and Robert Roteman, MD, will join Vivo as medical directors.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC News

Advertisement

Comments are closed.